{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:49:49Z","timestamp":1777002589796,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11914-016-0325-0","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T07:12:09Z","timestamp":1475305929000},"page":"249-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis"],"prefix":"10.1007","volume":"14","author":[{"given":"Lucia","family":"Gomez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayala","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davy","family":"Vancampfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Gaughran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"issue":"9321","key":"325_CR1","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929\u201336.","journal-title":"Lancet"},{"issue":"6","key":"325_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","volume":"2","author":"C Cooper","year":"1992","unstructured":"Cooper C, Campion G, Melton III L. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285\u20139.","journal-title":"Osteoporos Int"},{"issue":"5","key":"325_CR3","doi-asserted-by":"crossref","first-page":"S505","DOI":"10.1016\/8756-3282(95)00258-4","volume":"17","author":"BL Riggs","year":"1995","unstructured":"Riggs BL, Melton LR. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17(5):S505\u201311.","journal-title":"Bone"},{"issue":"6","key":"325_CR4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/acps.12313","volume":"130","author":"B Stubbs","year":"2014","unstructured":"Stubbs B et al. A meta\u2010analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatr Scand. 2014;130(6):470\u201386. This study identifies an increased prevalence of osteoporosis in people with shizophrenia and highlights potential risk factors for this group.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"325_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006842-199509000-00011","volume":"57","author":"U Halbreich","year":"1995","unstructured":"Halbreich U et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med. 1995;57(5):485\u201391.","journal-title":"Psychosom Med"},{"key":"325_CR6","doi-asserted-by":"crossref","unstructured":"De Hert M, Detraux J, Stubbs B. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis\/osteoporotic fractures in patients with schizophrenia: a critical literature review. Expert Opinion on Drug Safety, 2016 (in press)","DOI":"10.1517\/14740338.2016.1167873"},{"issue":"2","key":"325_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.genhosppsych.2015.01.004","volume":"37","author":"B Stubbs","year":"2015","unstructured":"Stubbs B et al. Schizophrenia and the risk of fractures: a systematic review and comparative meta-analysis. Gen Hosp Psychiatry. 2015;37(2):126\u201333.","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"325_CR8","first-page":"1478","volume":"76","author":"C-S Wu","year":"2015","unstructured":"Wu C-S et al. Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case\u2013control study. J Clin Psychol. 2015;76(9):1478\u2013223. An investigation into the association between antipsychotic medication and risk of hip fracture in patients with schizophrenia.","journal-title":"J Clin Psychol"},{"key":"325_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0306-4530(02)00129-4","volume":"28","author":"U Naidoo","year":"2003","unstructured":"Naidoo U, Goff D, Klibanski A. Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology. 2003;28:97\u2013108.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"325_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-016-0780-2","volume":"16","author":"J Lally","year":"2016","unstructured":"Lally J et al. Clinical correlates of vitamin D deficiency in established psychosis. BMC Psychiatry. 2016;16(1):1.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"325_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.schres.2013.08.036","volume":"150","author":"M Crews","year":"2013","unstructured":"Crews M et al. Vitamin D deficiency in first episode psychosis: a case\u2013control study. Schizophr Res. 2013;150(2):533\u20137. This paper identifies low levels of vitamin D in unmedicated patients with first episode psychosis.","journal-title":"Schizophr Res"},{"issue":"3","key":"325_CR12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2014.6930","volume":"175","author":"L-A Fraser","year":"2015","unstructured":"Fraser L-A et al. Falls and fractures with atypical antipsychotic medication use: a population-based cohort study. JAMA Intern Med. 2015;175(3):450\u20132.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"325_CR13","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1007\/s11999-013-3138-9","volume":"471","author":"ME Menendez","year":"2013","unstructured":"Menendez ME et al. Do psychiatric comorbidities influence inpatient death, adverse events, and discharge after lower extremity fractures? Clin Orthop Relat Res. 2013;471(10):3336\u201348. A discussion of the increased negative impact of fractures on patients with schizophrenia.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"325_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.106.023671","volume":"190","author":"L Howard","year":"2007","unstructured":"Howard L, Kirkwood G, Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry. 2007;190(2):129\u201334.","journal-title":"Br J Psychiatry"},{"issue":"47","key":"325_CR15","volume":"94","author":"P-T Tseng","year":"2015","unstructured":"Tseng P-T et al. Bone mineral density in schizophrenia: an update of current meta-analysis and literature review under guideline of PRISMA. Medicine. 2015;94(47), e1967.","journal-title":"Medicine"},{"issue":"15","key":"325_CR16","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"issue":"4","key":"325_CR17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"325_CR18","unstructured":"DSM-IV, A.P.A.T.F.o. DSM-IV draft criteria. 1993: Amer Psychiatric Pub Incorporated"},{"key":"325_CR19","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"WHO","year":"1992","unstructured":"WHO. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992."},{"issue":"7041","key":"325_CR20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254\u20139.","journal-title":"BMJ"},{"issue":"6","key":"325_CR21","first-page":"1173","volume":"39","author":"A Wyszogrodzka-Kucharska","year":"2004","unstructured":"Wyszogrodzka-Kucharska A, Rabe-Jab\u0142o\u0144ska J. Decrease in mineral bone density in schizophrenic patients treated with 2nd generation antipsychotics. Psychiatr Pol. 2004;39(6):1173\u201384.","journal-title":"Psychiatr Pol"},{"issue":"3","key":"325_CR22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000329391","volume":"94","author":"M Doknic","year":"2011","unstructured":"Doknic M et al. Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone. Neuroendocrinology. 2011;94(3):246\u201354.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"325_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2012.10.031","volume":"143","author":"C Leeuw Van Der","year":"2013","unstructured":"Van Der Leeuw C et al. Bone mineral density as a marker of cumulative endogenous estrogen exposure: Relationship to background genetic risk of psychotic disorder. Schizophr Res. 2013;143(1):25\u201331.","journal-title":"Schizophr Res"},{"issue":"1","key":"325_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/JCP.0b013e3182075587","volume":"31","author":"JM Bolton","year":"2011","unstructured":"Bolton JM et al. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol. 2011;31(1):56\u201360.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"325_CR25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/ndt\/14.8.1917","volume":"14","author":"MW Taal","year":"1999","unstructured":"Taal MW et al. Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients. Nephrol Dial Transplant. 1999;14(8):1917\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"325_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1359\/JBMR.051205","volume":"21","author":"A Stewart","year":"2006","unstructured":"Stewart A, Kumar V, Reid DM. Long\u2010term fracture prediction by DXA and QUS: a 10\u2010year prospective study. J Bone Miner Res. 2006;21(3):413\u20138.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"325_CR27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/YCO.0b013e328355e1ac","volume":"25","author":"T Kishimoto","year":"2012","unstructured":"Kishimoto T et al. Osteoporosis and fracture risk in people with schizophrenia. Curr Opin Psychiatry. 2012;25(5):415\u201329.","journal-title":"Curr Opin Psychiatry"},{"key":"325_CR28","doi-asserted-by":"crossref","unstructured":"Hummer M, et al. Osteoporosis in patients with schizophrenia. American Journal of Psychiatry. 2005","DOI":"10.1176\/appi.ajp.162.1.162"},{"issue":"1","key":"325_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004850-200401000-00006","volume":"19","author":"M Lean","year":"2004","unstructured":"Lean M, De Smedt G. Schizophrenia and osteoporosis. Int Clin Psychopharmacol. 2004;19(1):31\u20135.","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"325_CR30","first-page":"1143","volume":"39","author":"A Wyszogrodzka-Kucharska","year":"2004","unstructured":"Wyszogrodzka-Kucharska A, Kunert-Radek J, Rabe-Jab\u0142o\u0144ska J. Prolactin secretion disturbances in schizophrenic patients treated with 2nd generation antipsychotics\u2014risperidone and olanzapine. Psychiatr Pol. 2004;39(6):1143\u201355.","journal-title":"Psychiatr Pol"},{"issue":"3","key":"325_CR31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1467-8721.ep10768783","volume":"1","author":"J Cohen","year":"1992","unstructured":"Cohen J. Statistical power analysis. Curr Dir Psychol Sci. 1992;1(3):98\u2013101.","journal-title":"Curr Dir Psychol Sci"},{"key":"325_CR32","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088\u20131101","DOI":"10.2307\/2533446"},{"issue":"7109","key":"325_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"2","key":"325_CR34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel\u2010plot-based method of testing and adjusting for publication bias in meta\u2010analysis. Biometrics. 2000;56(2):455\u201363.","journal-title":"Biometrics"},{"issue":"2","key":"325_CR35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hup.2387","volume":"29","author":"M Wang","year":"2014","unstructured":"Wang M et al. Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12\u2010month prospective study. Hum Psychopharmacol Clin Exp. 2014;29(2):183\u20139.","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"2\u20133","key":"325_CR36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.schres.2004.07.016","volume":"73","author":"N Maric","year":"2005","unstructured":"Maric N et al. Cumulative exposure to estrogen and psychosis: a peak bone mass, case\u2013control study in first-episode psychosis. Schizophr Res. 2005;73(2\u20133):351\u20135.","journal-title":"Schizophr Res"},{"issue":"4","key":"325_CR37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5350\/DAJPN2011240407","volume":"24","author":"E Ko\u00e7er","year":"2011","unstructured":"Ko\u00e7er E. Comparison of bone mineral density levels in young-adult patients with schizophrenia and healthy controls. D\u00fc\u015f\u00fcnen Adam: The Journal of Psychiatry and Neurological Sciences. 2011;24(4):314\u201320.","journal-title":"D\u00fc\u015f\u00fcnen Adam: The Journal of Psychiatry and Neurological Sciences"},{"issue":"4","key":"325_CR38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/JCP.0b013e318221b123","volume":"31","author":"D-U Jung","year":"2011","unstructured":"Jung D-U et al. Bone mineral density and osteoporosis risk in older patients with schizophrenia. J Clin Psychopharmacol. 2011;31(4):406\u201310.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"325_CR39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4088\/JCP.v67n0909","volume":"67","author":"D-U Jung","year":"2006","unstructured":"Jung D-U et al. Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study. J Clin Psychiatry. 2006;67(9):1391\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"325_CR40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5455\/bcp.20110510114010","volume":"21","author":"M Bilici","year":"2011","unstructured":"Bilici M et al. The effect of chronic use of antipsychotics on the bone, breast and cervix. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology. 2011;21(2):114\u201321.","journal-title":"Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology"},{"issue":"7","key":"325_CR41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/00207450290025833","volume":"112","author":"M Bilici","year":"2002","unstructured":"Bilici M et al. Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int J Neurosci. 2002;112(7):817\u201328.","journal-title":"Int J Neurosci"},{"issue":"4","key":"325_CR42","first-page":"402","volume":"19","author":"\u00d6 Alt\u0131nda\u011f","year":"2009","unstructured":"Alt\u0131nda\u011f \u00d6 et al. Bone mineral density in schizophrenia patients on antipsychotics. KLINIK PSIKOFARMAKOLOJI BULTENI-Bulletin of Clinical Psychopharmacology. 2009;19(4):402\u20136.","journal-title":"KLINIK PSIKOFARMAKOLOJI BULTENI-Bulletin of Clinical Psychopharmacology"},{"issue":"08","key":"325_CR43","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1017\/S003329170800319X","volume":"38","author":"N Bergemann","year":"2008","unstructured":"Bergemann N et al. High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychol Med. 2008;38(08):1195\u2013201.","journal-title":"Psychol Med"},{"issue":"1","key":"325_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-10-1","volume":"10","author":"J-H Renn","year":"2009","unstructured":"Renn J-H et al. Bone mass in schizophrenia and normal populations across different decades of life. BMC Musculoskelet Disord. 2009;10(1):1.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"325_CR45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway. Schizophr Bull. 2009;35(3):549\u201362.","journal-title":"Schizophr Bull"},{"issue":"3","key":"325_CR46","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4088\/JCP.v69n0307","volume":"69","author":"T Kishimoto","year":"2008","unstructured":"Kishimoto T et al. Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia. J Clin Psychiatry. 2008;69(3):1478\u2013391.","journal-title":"J Clin Psychiatry"},{"key":"325_CR47","doi-asserted-by":"crossref","unstructured":"Eriksen E, Glerup H. Pathogenesis of osteoporosis. In: Management of fractures in severely osteoporotic bone. Springer; 2000. pp. 13\u201332","DOI":"10.1007\/978-1-4471-3825-9_2"},{"issue":"1","key":"325_CR48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00586-008-0847-y","volume":"18","author":"N Suzuki","year":"2009","unstructured":"Suzuki N, Ogikubo O, Hansson T. The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: its relation to fracture level, type of fracture and grade of fracture deformation. Eur Spine J. 2009;18(1):77\u201388.","journal-title":"Eur Spine J"},{"key":"325_CR49","first-page":"205","volume":"6","author":"CC Wong","year":"2013","unstructured":"Wong CC, McGirt MJ. Vertebral compression fractures: a review of current management and multimodal therapy. J Multidiscip Healthc. 2013;6:205\u201314. A review of multidisciplinary treatment plans for vertebral fractures.","journal-title":"J Multidiscip Healthc"},{"issue":"11","key":"325_CR50","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/j.pain.0000000000000304","volume":"156","author":"B Stubbs","year":"2015","unstructured":"Stubbs B et al. Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies. Pain. 2015;156(11):2121\u201331.","journal-title":"Pain"},{"issue":"01","key":"325_CR51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1017\/S1041610208007849","volume":"21","author":"B Stubbs","year":"2009","unstructured":"Stubbs B, Zapata-Bravo E, Haw C. Screening for osteoporosis: a survey of older psychiatric inpatients at a tertiary referral centre. Int Psychogeriatr. 2009;21(01):180\u20136.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"325_CR52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","volume":"76","author":"J Leon de","year":"2005","unstructured":"de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2):135\u201357.","journal-title":"Schizophr Res"},{"issue":"12","key":"325_CR53","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1017\/S0033291715000562","volume":"45","author":"P Gardner-Sood","year":"2015","unstructured":"Gardner-Sood P et al. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med. 2015;45(12):2619\u201329.","journal-title":"Psychol Med"},{"issue":"2","key":"325_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155\u201362.","journal-title":"Osteoporos Int"},{"issue":"5","key":"325_CR55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11914-015-0278-8","volume":"13","author":"NE Cusano","year":"2015","unstructured":"Cusano NE. Skeletal effects of smoking. Curr Osteoporos Rep. 2015;13(5):302\u20139. This paper discusses the significant negative impact of smoking, which has an increased prevalence amongst patients with schizophrenia, on bone health.","journal-title":"Curr Osteoporos Rep"},{"issue":"12","key":"325_CR56","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s001980070020","volume":"11","author":"R Heaney","year":"2000","unstructured":"Heaney R et al. Peak bone mass. Osteoporos Int. 2000;11(12):985\u20131009.","journal-title":"Osteoporos Int"},{"issue":"2","key":"325_CR57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50\u00a0years in the UK. Maturitas. 2009;62(2):105\u20138.","journal-title":"Maturitas"},{"key":"325_CR58","doi-asserted-by":"crossref","unstructured":"Shim J-C, et al. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. American Journal of Psychiatry. 2007","DOI":"10.1176\/appi.ajp.2007.06071075"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-016-0325-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T06:34:35Z","timestamp":1589697275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-016-0325-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s11914-016-0325-0","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,1]]}}}